PARADIGM BIOPHARMACEUTICALS LIMITED.. - Announcements

Market Cap $103.1M Add to my watchlist

Paradigm Biopharmaceuticals Limited is a late-stage drug development company. The Company... Paradigm Biopharmaceuticals Limited is a late-stage drug development company. The Company is engaged in discovering, developing, and delivering pharmaceutical therapies. It is focused on the development of injectable pentosan polysulfate sodium (iPPS/PPS) for the treatment of osteoarthritis (OA) and mucopolysaccharidosis (MPS). Pentosan polysulfate sodium is a semi-synthetic drug manufactured from the wood chips of European beech trees. Extracted glucurono-xylans are sulfated to produce a negatively charged product that mimics glycosaminoglycans (GAGs). It develops PPS under the brand name Zilosul. PPS also inhibits the synthesis of the metalloproteinase, MMP-3 (Troeberg) involved in degrading cartilage. PPS also include treatment of joint function, mobility, and pain in patients with MPS; treating alphavirus-induced arthralgia (such as Ross River virus and Chikungunya); chronic heart failure (HF) and acute respiratory distress syndrome (ARDS).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

PAR	Change in substantial holding		22/05/24	8.51MB	Share
PAR	Application for quotation of securities - PAR		20/05/24	15.51KB	Share
PAR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	325KB	Share
PAR	Notification of cessation of securities - PAR		26/04/24	13.22KB	Share
PAR	Type D Response Submitted and Received by the US FDA	PRICE SENSITIVE	19/04/24	157.42KB	Share
PAR	Notification of cessation of securities - PAR		05/04/24	13.23KB	Share
PAR	PAR to present at NWR Healthcare Conference		20/03/24	90.2KB	Share
PAR	Change of Director's Interest Notice		08/03/24	169.7KB	Share
PAR	Change of Director's Interest Notice		08/03/24	180.97KB	Share
PAR	Final Director's Interest Notice		06/03/24	150.9KB	Share
PAR	Initial Director's Interest Notice		04/03/24	157.18KB	Share
PAR	Paradigm Board Changes		04/03/24	135.46KB	Share
PAR	Notification regarding unquoted securities - PAR		29/02/24	16.25KB	Share
PAR	PAR Employee Performance Rights Plan Issue		29/02/24	112.65KB	Share
PAR	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/24	3.77MB	Share
PAR	Notification regarding unquoted securities - PAR		13/02/24	17.5KB	Share
PAR	Proposed issue of securities - PAR		12/02/24	23.96KB	Share
PAR	PAR Appoints Business Development Consultant		09/02/24	143.13KB	Share
PAR	Primary Endpoint Achieved in Phase 2 MPS VI Trial	PRICE SENSITIVE	09/02/24	387.82KB	Share
PAR	Paradigm Receives $7.36m R&D Tax Incentive Refund	PRICE SENSITIVE	07/02/24	61KB	Share
PAR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	350.17KB	Share
PAR	Notification of cessation of securities - PAR		30/01/24	21.97KB	Share
PAR	Application for quotation of securities - PAR		30/01/24	24.1KB	Share
PAR	PAR Selected for Major OA Conference Presentations		30/01/24	127.74KB	Share
PAR	Notice of release of escrowed securities		15/01/24	299.38KB	Share
PAR	Change in substantial holding		06/12/23	225.29KB	Share
PAR	Change of Director's Interest Notice - Fisher		01/12/23	175.33KB	Share
PAR	Change of Director's Interest Notice - Rennie		30/11/23	181.58KB	Share
PAR	Notification of cessation of securities - PAR		30/11/23	21.48KB	Share
PAR	Application for quotation of securities - PAR		30/11/23	24.73KB	Share
PAR	Results of Meeting		29/11/23	286.34KB	Share
PAR	2023 AGM Company Update		29/11/23	5.6MB	Share
PAR	2023 AGM Chairman Address		29/11/23	105.44KB	Share
PAR	Security Class Reinstatement to Quotation PARO	PRICE SENSITIVE	28/11/23	86.83KB	Share
PAR	Listing of Options - Top 20 Holders and Distribution Reports		27/11/23	77.91KB	Share
PAR	Application for quotation of securities - PAR		27/11/23	28.91KB	Share
PAR	Successful completion of Retail Entitlement Offer	PRICE SENSITIVE	23/11/23	138.29KB	Share
PAR	Security Class Suspension from Quotation PARO	PRICE SENSITIVE	21/11/23	89.1KB	Share
PAR	Application for quotation of securities - PAR		20/11/23	24.13KB	Share
PAR	PAR Pre-AGM Update		20/11/23	166.74KB	Share
PAR	Notice of release of escrowed securities		10/11/23	295.15KB	Share
PAR	Application for quotation of securities - PAR		08/11/23	26.91KB	Share
PAR	Retail Entitlement Offer Open		06/11/23	128.5KB	Share
PAR	Addendum to Notice of Meeting		03/11/23	693.49KB	Share
PAR	Paradigm to Recommence Trading	PRICE SENSITIVE	01/11/23	81.34KB	Share
PAR	Proposed issue of securities - PAR		31/10/23	30.43KB	Share
PAR	Update - Proposed issue of securities - PAR		31/10/23	48.67KB	Share
PAR	Replacement Entitlement Offer and Placement Prospectus	PRICE SENSITIVE	31/10/23	567.84KB	Share
PAR	PAR Successful Placement and Fully Underwritten ANREO	PRICE SENSITIVE	31/10/23	141.62KB	Share
PAR	Update - Proposed issue of securities - PAR		30/10/23	46.32KB	Share
PAR	Entitlement Offer and Placement Prospectus	PRICE SENSITIVE	30/10/23	525.55KB	Share
PAR	Proposed issue of securities - PAR		30/10/23	47.97KB	Share
PAR	Investor Presentation - $30m Capital Raise	PRICE SENSITIVE	30/10/23	10.88MB	Share
PAR	Paradigm Launches $30M Capital Raising	PRICE SENSITIVE	30/10/23	166.04KB	Share
PAR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/10/23	302.47KB	Share
PAR	Trading Halt	PRICE SENSITIVE	30/10/23	274.36KB	Share
PAR	Notice of Annual General Meeting/Proxy Form		25/10/23	467.1KB	Share
PAR	Final Director's Interest Notice		23/10/23	150.44KB	Share
PAR	Resignation of Non-executive Director		20/10/23	83.31KB	Share
PAR	iPPS Increases Cartilage Thickness in Phase 2 Trial	PRICE SENSITIVE	18/10/23	6.69MB	Share
PAR	Trading Halt	PRICE SENSITIVE	16/10/23	250.96KB	Share
PAR	iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS	PRICE SENSITIVE	10/10/23	7.37MB	Share
PAR	Trading Halt	PRICE SENSITIVE	06/10/23	259.19KB	Share
PAR	Date of AGM & Closing Date for Director Nominations		03/10/23	83.54KB	Share
PAR	Change of Share Registry Details		22/09/23	269.83KB	Share
PAR	Application for quotation of securities - PAR		13/09/23	24.08KB	Share
PAR	Corporate Governance Statement		01/09/23	217.79KB	Share
PAR	Appendix 4G		01/09/23	261.77KB	Share
PAR	Notice of release of escrowed securities		01/09/23	295.07KB	Share
PAR	Paradigm Accepted for Presentations at Major Conferences		01/09/23	178.2KB	Share
PAR	2023 Annual Report and Appendix 4E	PRICE SENSITIVE	25/08/23	3.3MB	Share
PAR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/23	373.8KB	Share
PAR	Study demonstrates Bene PPS is unique		27/07/23	150.57KB	Share
PAR	Application for quotation of securities - PAR		20/07/23	24.09KB	Share
PAR	Notice of release of escrowed securities		10/07/23	295.36KB	Share
PAR	PAR Reports Phase 3 Clinical Trial Update	PRICE SENSITIVE	04/07/23	194.03KB	Share
PAR	Notification of cessation of securities - PAR		29/06/23	23.45KB	Share
PAR	Primary and Secondary endpoints met in MPS I Trial	PRICE SENSITIVE	06/06/23	183.19KB	Share
PAR	iPPS shows 3-year equivalent durability in OA Canine Study	PRICE SENSITIVE	01/06/23	423.9KB	Share
PAR	Change of Director's Interest Notice - Fisher		22/05/23	174.52KB	Share
PAR	Change of Director's Interest Notice - Rennie		17/05/23	178.57KB	Share
PAR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/23	327.15KB	Share
PAR	PAR Phase 2 MPS VI clinical trial completes enrolment		28/04/23	253.64KB	Share
PAR	iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study	PRICE SENSITIVE	04/04/23	5.73MB	Share
PAR	Trading Halt	PRICE SENSITIVE	31/03/23	624.8KB	Share
PAR	PAR Poster Presentation to OARSI World Congress 2023		28/03/23	514.15KB	Share
PAR	Notification of cessation of securities - PAR		27/03/23	23.65KB	Share
PAR	NWR Virtual Healthcare Conference Presentation		22/03/23	4.93MB	Share
PAR	Paradigm to present at the NWR Virtual Healthcare Conference		21/03/23	121.14KB	Share
PAR	PAR Receives European Regulatory and Ethics Approval		14/03/23	149.62KB	Share
PAR	Change of Chief Financial Officer		03/03/23	135.11KB	Share
PAR	Notification of cessation of securities - PAR		02/03/23	21.61KB	Share
PAR	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/23	2.25MB	Share
PAR	Paradigm Increases Presence at OARSI World Congress 2023		02/02/23	120.03KB	Share
PAR	Application for quotation of securities - PAR		31/01/23	24.18KB	Share
PAR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/23	439.51KB	Share
PAR	Notice of release of escrowed securities		19/01/23	254.64KB	Share
PAR	Paradigm Presentation to JP Morgan Healthcare Conference		11/01/23	6.7MB	Share
PAR	Appendix 4G & 2022 Corporate Governance Statement		10/01/23	454.66KB	Share
PAR	Notification of cessation of securities - PAR		30/12/22	27.33KB	Share

PAR Change in substantial holding
22/05/24		8.51MB	Share
PAR Application for quotation of securities - PAR
20/05/24		15.51KB	Share
PAR Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	325KB	Share
PAR Notification of cessation of securities - PAR
26/04/24		13.22KB	Share
PAR Type D Response Submitted and Received by the US FDA
19/04/24	PRICE SENSITIVE	157.42KB	Share
PAR Notification of cessation of securities - PAR
05/04/24		13.23KB	Share
PAR PAR to present at NWR Healthcare Conference
20/03/24		90.2KB	Share
PAR Change of Director's Interest Notice
08/03/24		169.7KB	Share
PAR Change of Director's Interest Notice
08/03/24		180.97KB	Share
PAR Final Director's Interest Notice
06/03/24		150.9KB	Share
PAR Initial Director's Interest Notice
04/03/24		157.18KB	Share
PAR Paradigm Board Changes
04/03/24		135.46KB	Share
PAR Notification regarding unquoted securities - PAR
29/02/24		16.25KB	Share
PAR PAR Employee Performance Rights Plan Issue
29/02/24		112.65KB	Share
PAR Half Yearly Report and Accounts
28/02/24	PRICE SENSITIVE	3.77MB	Share
PAR Notification regarding unquoted securities - PAR
13/02/24		17.5KB	Share
PAR Proposed issue of securities - PAR
12/02/24		23.96KB	Share
PAR PAR Appoints Business Development Consultant
09/02/24		143.13KB	Share
PAR Primary Endpoint Achieved in Phase 2 MPS VI Trial
09/02/24	PRICE SENSITIVE	387.82KB	Share
PAR Paradigm Receives $7.36m R&D Tax Incentive Refund
07/02/24	PRICE SENSITIVE	61KB	Share
PAR Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	350.17KB	Share
PAR Notification of cessation of securities - PAR
30/01/24		21.97KB	Share
PAR Application for quotation of securities - PAR
30/01/24		24.1KB	Share
PAR PAR Selected for Major OA Conference Presentations
30/01/24		127.74KB	Share
PAR Notice of release of escrowed securities
15/01/24		299.38KB	Share
PAR Change in substantial holding
06/12/23		225.29KB	Share
PAR Change of Director's Interest Notice - Fisher
01/12/23		175.33KB	Share
PAR Change of Director's Interest Notice - Rennie
30/11/23		181.58KB	Share
PAR Notification of cessation of securities - PAR
30/11/23		21.48KB	Share
PAR Application for quotation of securities - PAR
30/11/23		24.73KB	Share
PAR Results of Meeting
29/11/23		286.34KB	Share
PAR 2023 AGM Company Update
29/11/23		5.6MB	Share
PAR 2023 AGM Chairman Address
29/11/23		105.44KB	Share
PAR Security Class Reinstatement to Quotation PARO
28/11/23	PRICE SENSITIVE	86.83KB	Share
PAR Listing of Options - Top 20 Holders and Distribution Reports
27/11/23		77.91KB	Share
PAR Application for quotation of securities - PAR
27/11/23		28.91KB	Share
PAR Successful completion of Retail Entitlement Offer
23/11/23	PRICE SENSITIVE	138.29KB	Share
PAR Security Class Suspension from Quotation PARO
21/11/23	PRICE SENSITIVE	89.1KB	Share
PAR Application for quotation of securities - PAR
20/11/23		24.13KB	Share
PAR PAR Pre-AGM Update
20/11/23		166.74KB	Share
PAR Notice of release of escrowed securities
10/11/23		295.15KB	Share
PAR Application for quotation of securities - PAR
08/11/23		26.91KB	Share
PAR Retail Entitlement Offer Open
06/11/23		128.5KB	Share
PAR Addendum to Notice of Meeting
03/11/23		693.49KB	Share
PAR Paradigm to Recommence Trading
01/11/23	PRICE SENSITIVE	81.34KB	Share
PAR Proposed issue of securities - PAR
31/10/23		30.43KB	Share
PAR Update - Proposed issue of securities - PAR
31/10/23		48.67KB	Share
PAR Replacement Entitlement Offer and Placement Prospectus
31/10/23	PRICE SENSITIVE	567.84KB	Share
PAR PAR Successful Placement and Fully Underwritten ANREO
31/10/23	PRICE SENSITIVE	141.62KB	Share
PAR Update - Proposed issue of securities - PAR
30/10/23		46.32KB	Share
PAR Entitlement Offer and Placement Prospectus
30/10/23	PRICE SENSITIVE	525.55KB	Share
PAR Proposed issue of securities - PAR
30/10/23		47.97KB	Share
PAR Investor Presentation - $30m Capital Raise
30/10/23	PRICE SENSITIVE	10.88MB	Share
PAR Paradigm Launches $30M Capital Raising
30/10/23	PRICE SENSITIVE	166.04KB	Share
PAR Quarterly Activities/Appendix 4C Cash Flow Report
30/10/23	PRICE SENSITIVE	302.47KB	Share
PAR Trading Halt
30/10/23	PRICE SENSITIVE	274.36KB	Share
PAR Notice of Annual General Meeting/Proxy Form
25/10/23		467.1KB	Share
PAR Final Director's Interest Notice
23/10/23		150.44KB	Share
PAR Resignation of Non-executive Director
20/10/23		83.31KB	Share
PAR iPPS Increases Cartilage Thickness in Phase 2 Trial
18/10/23	PRICE SENSITIVE	6.69MB	Share
PAR Trading Halt
16/10/23	PRICE SENSITIVE	250.96KB	Share
PAR iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS
10/10/23	PRICE SENSITIVE	7.37MB	Share
PAR Trading Halt
06/10/23	PRICE SENSITIVE	259.19KB	Share
PAR Date of AGM & Closing Date for Director Nominations
03/10/23		83.54KB	Share
PAR Change of Share Registry Details
22/09/23		269.83KB	Share
PAR Application for quotation of securities - PAR
13/09/23		24.08KB	Share
PAR Corporate Governance Statement
01/09/23		217.79KB	Share
PAR Appendix 4G
01/09/23		261.77KB	Share
PAR Notice of release of escrowed securities
01/09/23		295.07KB	Share
PAR Paradigm Accepted for Presentations at Major Conferences
01/09/23		178.2KB	Share
PAR 2023 Annual Report and Appendix 4E
25/08/23	PRICE SENSITIVE	3.3MB	Share
PAR Quarterly Activities/Appendix 4C Cash Flow Report
31/07/23	PRICE SENSITIVE	373.8KB	Share
PAR Study demonstrates Bene PPS is unique
27/07/23		150.57KB	Share
PAR Application for quotation of securities - PAR
20/07/23		24.09KB	Share
PAR Notice of release of escrowed securities
10/07/23		295.36KB	Share
PAR PAR Reports Phase 3 Clinical Trial Update
04/07/23	PRICE SENSITIVE	194.03KB	Share
PAR Notification of cessation of securities - PAR
29/06/23		23.45KB	Share
PAR Primary and Secondary endpoints met in MPS I Trial
06/06/23	PRICE SENSITIVE	183.19KB	Share
PAR iPPS shows 3-year equivalent durability in OA Canine Study
01/06/23	PRICE SENSITIVE	423.9KB	Share
PAR Change of Director's Interest Notice - Fisher
22/05/23		174.52KB	Share
PAR Change of Director's Interest Notice - Rennie
17/05/23		178.57KB	Share
PAR Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23	PRICE SENSITIVE	327.15KB	Share
PAR PAR Phase 2 MPS VI clinical trial completes enrolment
28/04/23		253.64KB	Share
PAR iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
04/04/23	PRICE SENSITIVE	5.73MB	Share
PAR Trading Halt
31/03/23	PRICE SENSITIVE	624.8KB	Share
PAR PAR Poster Presentation to OARSI World Congress 2023
28/03/23		514.15KB	Share
PAR Notification of cessation of securities - PAR
27/03/23		23.65KB	Share
PAR NWR Virtual Healthcare Conference Presentation
22/03/23		4.93MB	Share
PAR Paradigm to present at the NWR Virtual Healthcare Conference
21/03/23		121.14KB	Share
PAR PAR Receives European Regulatory and Ethics Approval
14/03/23		149.62KB	Share
PAR Change of Chief Financial Officer
03/03/23		135.11KB	Share
PAR Notification of cessation of securities - PAR
02/03/23		21.61KB	Share
PAR Half Yearly Report and Accounts
27/02/23	PRICE SENSITIVE	2.25MB	Share
PAR Paradigm Increases Presence at OARSI World Congress 2023
02/02/23		120.03KB	Share
PAR Application for quotation of securities - PAR
31/01/23		24.18KB	Share
PAR Quarterly Activities/Appendix 4C Cash Flow Report
31/01/23	PRICE SENSITIVE	439.51KB	Share
PAR Notice of release of escrowed securities
19/01/23		254.64KB	Share
PAR Paradigm Presentation to JP Morgan Healthcare Conference
11/01/23		6.7MB	Share
PAR Appendix 4G & 2022 Corporate Governance Statement
10/01/23		454.66KB	Share
PAR Notification of cessation of securities - PAR
30/12/22		27.33KB	Share

REFRESH

1 2 3 4 5

(20min delay)
Last 30.0¢		Change 0.005(1.69%)		Mkt cap ! $103.1M

Open	High	Low	Value	Volume
30.0¢	30.0¢	29.5¢	$12.30K	41.06K

Buyers (Bids)

No.	Vol.	Price($)
6	74788	29.5¢

Sellers (Offers)

Price($)	Vol.	No.
30.0¢	6862	4

View Market Depth

No.	Vol.	Price($)
7	78021	0.295
7	37149	0.290
5	61933	0.285
5	113745	0.280
3	13893	0.275

Price($)	Vol.	No.
0.300	4862	3
0.305	30425	5
0.310	19907	2
0.315	59184	6
0.320	122010	6

Last trade - 12.55pm 22/07/2024 (20 minute delay)


Last 29.5¢		Change 0.005 ( 0.00 %)
Open	High	Low	Volume
30.0¢	30.0¢	29.5¢	5200
Last updated 12.24pm 22/07/2024 ?

PAR (ASX) Chart

PARADIGM BIOPHARMACEUTICALS LIMITED.. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available